Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0002081359-26-000002

Chief Science Officer sold 3,873 shares at $16.35 ($63,324)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lerner Lorena Raquel Chief Science Officer 2026-02-18 Sale −3,873 $16.35 $63,324 31,127 D: show line 1 in the form
Open-market sales · 3,873 sh · avg $16.35 · $63,324
Loading xslF345X05/form4-02202026_040205.xml…